Crescent Biopharma Inc. entered an underwriting agreement with Jefferies LLC and TD Securities to sell 8,094,793 shares and relevant warrants. This capital raise allows the Cayman Islands company to proceed with its planned public offering.
Crescent Biopharma Inc. entered an underwriting agreement with Jefferies LLC and TD Securities to sell 8,094,793 shares and relevant warrants. This capital raise allows the Cayman Islands company to proceed with its planned public offering.